Cognitive response to estradiol in postmenopausal women is modified by high cortisol

Neurobiology of Aging

Volumn 33, Issue 4, 2012, Pages 829.e9-829.e20

  Baker, Laura D ^a,b   Asthana, Sanjay ^c,d   Cholerton, Brenna A ^a,b   Wilkinson, Charles W ^a,b   Plymate, Stephen R ^a,b   Green, Pattie S ^a,b   Merriam, George R ^a,b   Fishel, Mark A ^a,b   Watson, G Stennis ^a,b   Cherrier, Monique M ^a,b   Kletke, Monica L ^b   Mehta, Pankaj D ^e   Craft, Suzanne ^a,b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^c WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

^d UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^e NEW YORK STATE INSTITUTE FOR BASIC RESEARCH IN DEVELOPMENTAL DISABILITIES   (United States)

Author keywords

Amyloid; A ; Cognition; Estrogen; Executive function; Hypothalamic pituitary adrenal (HPA); IGF; Memory; Postmenopausal; Stress

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; BIOLOGICAL MARKER; ESTRADIOL; HYDROCORTISONE; PLACEBO; SOMATOMEDIN C;

ADULT; AGED; AGING; AMYLOID BETA PROTEIN[1-42] BLOOD LEVEL; ARTICLE; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEGENERATIVE DISEASE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ESTRADIOL BLOOD LEVEL; FEMALE; HORMONE RESPONSE; HUMAN; PARALLEL DESIGN; PILL; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SELECTIVE ATTENTION; STRESS; TREATMENT DURATION; TREATMENT RESPONSE; VERBAL MEMORY; WORKING MEMORY;

EID: 84856953124     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2011.07.002     Document Type: Article

References (111)

1. Aleman A., Torres-Alemán I. Circulating insulin-like growth factor I and cognitive function: neuromodulation throughout the lifespan. Prog. Neurobiol 2009, 89:256-265.
2. Alhola P., Polo-Kantola P., Erkkola R., Portin R. Estrogen therapy and cognition: a 6-year single-blind follow-up study in postmenopausal women. Neurology 2006, 67:706-709.
3. Asthana S., Baker L.D., Craft S., Stanczyk F.Z., Veith R.C., Raskind M.A., Plymate S.R. High-dose estradiol improves cognition for women with AD: results of a randomized study. Neurology 2001, 57:605-612.
4. Asthana S., Brinton R.D., Henderson V.W., McEwen B.S., Morrison J.H., Schmidt P.J. Frontiers Proposal. National Institute on Aging "bench to bedside: estrogen as a case study". Age (Dordr) 2009, 31:199-210.
5. Asthana S., Craft S., Baker L.D., Raskind M.A., Birnbaum R.S., Lofgreen C.P., Veith R.C., Plymate S.R. Cognitive and neuroendocrine response to transdermal estrogen in postmenopausal women with Alzheimer's disease: results of a placebo-controlled, double-blind, pilot study. Psychoneuroendocrinology 1999, 24:657-677.
6. Atwood C.S., Meethal S.V., Liu T., Wilson A.C., Gallego M., Smith M.A., Bowen R.L. Dysregulation of the hypothalamic-pituitary-gonadal axis with menopause and andropause promotes neurodegenerative senescence. J. Neuropathol. Exp. Neurol 2005, 64:93-103.
7. Azcoitia I., Sierra A., Garcia-Segura L.M. Neuroprotective effects of estradiol in the adult rat hippocampus: interaction with insulin-like growth factor-I signalling. J. Neurosci. Res 1999, 58:815-822.
8. Baker L.D., Frank L.L., Foster-Schubert K., Green P.S., Wilkinson C.W., McTiernan A., Cholerton B.A., Plymate S.R., Fishel M.A., Watson G.S., Duncan G.E., Mehta P.D., Craft S. Aerobic exercise improves cognition for older adults with glucose intolerance, a risk factor for Alzheimer's disease. J. Alzheimers Dis 2010, 22:569-579.
9. Baker L.D., Frank L.L., Foster-Schubert K., Green P.S., Wilkinson C.W., McTiernan A., Plymate S.R., Fishel M.A., Watson G.S., Cholerton B.A., Duncan G.E., Mehta P.D., Craft S. Effects of aerobic exercise on mild cognitive impairment: A controlled trial. Arch. Neurol 2010, 67:1-9.
10. Balota D.A., Tse C.S., Hutchison K.A., Spieler D.H., Duchek J.M., Morris J.C. Predicting conversion to dementia of the Alzheimer's type in a healthy control sample: the power of errors in Stroop color naming. Psychol. Aging 2010, 25:208-218.
11. Bang P., Degerblad M., Thoren M., Schwander J., Blum W., Hall K. Insulin-like growth factor (IGF) I and II and IGF binding protein (IGFBP) 1, 2 and 3 in serum from patients with Cushing's syndrome. Acta Endocrinol. (Copenh) 1993, 128:397-404.
12. Banki C.M., Bissette G., Arato M., O'Connor L., Nemeroff C.B. CSF corticotropin-releasing factor-like immunoreactivity in depression and schizophrenia. Am. J. Psychiatry 1987, 144:873-877.
13. Barrett-Connor E., Kritz-Silverstein D. Estrogen replacement therapy and cognitive function in older women. JAMA 1993, 269:2637-2641.
14. Binder E.F., Schechtman K.B., Birge S.J., Williams D.B., Kohrt W.M. Effects of hormone replacement therapy on cognitive performance in elderly women. Maturitas 2001, 38:137-146.
15. Birge S.J. The role of estrogen in the treatment of Alzheimer's disease. Neurology 1997, 48:S36-S41.
16. Birkhäuser M. Depression, menopause and estrogens: is there a correlation?. Maturitas 2002, 41:S3-S8.
17. Borges M.H., Pinto A.C., DiNinno F.B., Camacho-Hübner C., Grossman A., Kater C.E., Lengyel A.M. IGF-I levels rise and GH responses to GHRH decrease during long-term prednisone treatment in man. J. Endocrinol. Invest 1999, 22:12-17.
18. Bowman R.E., Ferguson D., Luine V.N. Effects of chronic restraint stress and estradiol on open field activity, spatial memory, and monoaminergic neurotransmitters in ovariectomized rats. Neuroscience 2002, 113:401-410.
19. Brinton R.D. The healthy cell bias of estrogen action: mitochondrial bioenergetics and neurological implications. Trends Neurosci 2008, 31:529-537.
20. Bryan J., Luszcz M.A. Adult age differences in self-ordered pointing task performance: contributions from working memory, executive function and speed of information processing. J. Clin. Exp. Neuropsychol 2001, 23:608-619.
21. Buerger K., Frisoni G., Uspenskaya O., Ewers M., Zetterberg H., Geroldi C., Binetti G., Johannsen P., Rossini P.M., Wahlund L.O., Vellas B., Blennow K., Hampel H. Validation of Alzheimer's disease CSF and plasma biological markers: the multicentre reliability study of the pilot European Alzheimer'S Disease Neuroimaging Initiative (E-ADNI). Exp. Gerontol 2009, 44:579-585.
22. Burke H.M., Davis M.C., Otte C., Mohr D.C. Depression and cortisol responses to psychological stress: a meta-analysis. Psychoneuroendocrinology 2005, 30:846-856.
23. Catania C., Sotiropoulos I., Silva R., Onofri C., Breen K.C., Sousa N., Almeida O.F. The amyloidogenic potential and behavioral correlates of stress. Mol. Psychiatry 2009, 14:95-105.
24. Ceresini G., Freddi M., Morganti S., Rebecchi I., Modena A.B., Rinaldi M., Manca C., Amaducci A., Del Rio G., Valenti G. The effects of transdermal estradiol on the response to mental stress in postmenopausal women: a randomized trial. Am. J. Med 2000, 109:463-468.
25. Chopra K.K., Ravindran A., Kennedy S.H., Mackenzie B., Matthews S., Anisman H., Bagby R.M., Farvolden P., Levitan R.D. Sex differences in hormonal responses to a social stressor in chronic major depression. Psychoneuroendocrinology 2009, 34:1235-1241.
26. Cornelisse S., van Stegeren A.H., Joels M. Implications of psychosocial stress on memory formation in a typical male versus female student sample. Psychoneuroendocrinology 2011, 36:569-578.
27. Craft S., Asthana S., Newcomer J.W., Wilkinson C.W., Matos I.T., Baker L.D., Cherrier M., Lofgreen C., Latendresse S., Petrova A., Plymate S., Raskind M., Grimwood K., Veith R.C. Enhancement of memory in Alzheimer disease with insulin and somatostatin, but not glucose. Arch. Gen. Psychiatry 1999, 56:1135-1140.
28. Craig M.C., Brammer M., Maki P.M., Fletcher P.C., Daly E.M., Rymer J., Giampietro V., Picchioni M., Stahl D., Murphy D.G. The interactive effect of acute ovarian suppression and the cholinergic system on visuospatial working memory in young women. Psychoneuroendocrinology 2010, 35:987-1000.
29. Daniel J.M., Hulst J.L., Berbling J.L. Estradiol replacement enhances working memory in middle-aged rats when initiated immediately after ovariectomy but not after a long-term period of ovarian hormone deprivation. Endocrinology 2006, 147:607-614.
30. Darnaudéry M., Perez-Martin M., Bélizaire G., Maccari S., Garcia-Segura L.M. Insulin-like growth factor 1 reduces age-related disorders induced by prenatal stress in female rats. Neurobiol. Aging 2006, 27:119-127.
31. Davis S.R., Stuckey B.G., Norman R.J., Papalia M.A., Drillich A., Bell R.J. Effects of the route of estrogen administration on insulinlike growth factor-I, IGF binding protein-3, and insulin resistance in healthy postmenopausal women: results from a randomized, controlled study. Menopause 2008, 15:1065-1069.
32. Dayas C.V., Xu Y., Buller K.M., Day T.A. Effects of chronic oestrogen replacement on stress-induced activation of hypothalamic-pituitary-adrenal axis control pathways. J. Neuroendocrinol 2000, 12:784-794.
33. de Kloet E.R., Oitzl M.S., Joëls M. Stress and cognition: are corticosteroids good or bad guys?. Trends Neurosci 1999, 22:422-426.
34. Deuschle M., Blum W.F., Strasburger C.J., Schweiger U., Weber B., Körner A., Standhardt H., Gotthardt U., Schmider J., Pflaum C.D., Heuser I. Insulin-like growth factor-I (IGF-I) plasma concentrations are increased in depressed patients. Psychoneuroendocrinology 1997, 22:493-503.
35. Diorio D., Viau V., Meaney M.J. The role of the medial prefrontal cortex (cingulate gyrus) in the regulation of hypothalamic-pituitary-adrenal responses to stress. J. Neurosci 1993, 13:3839-3847.
36. Dumas J.A., Kutz A.M., Naylor M.R., Johnson J.V., Newhouse P.A. Increased memory load-related frontal activation after estradiol treatment in postmenopausal women. Horm. Behav 2010, 58:929-935.
37. Espeland M.A., Rapp S.R., Shumaker S.A., Brunner R., Manson J.E., Sherwin B.B., Hsia J., Margolis K.L., Hogan P.E., Wallace R., Dailey M., Freeman R., Hays J. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004, 291:2959-2968. Women's Health Initiative Memory Study.
38. Friedrich N., Alte D., Völzke H., Spilcke-Liss E., Lüdemann J., Lerch M.M., Kohlmann T., Nauck M., Wallaschofski H. Reference ranges of serum IGF-1 and IGFBP-3 levels in a general adult population: results of the Study of Health in Pomerania (SHIP). Growth Horm. IGF Res 2008, 18:228-237.
39. Garcia-Segura L.M., Arévalo M.A., Azcoitia I. Interactions of estradiol and insulin-like growth factor-I signalling in the nervous system: new advances. Prog. Brain Res 2010, 181:251-272.
40. Gianaros P.J., Jennings J.R., Sheu L.K., Greer P.J., Kuller L.H., Matthews K.A. Prospective reports of chronic life stress predict decreased grey matter volume in the hippocampus. Neuroimage 2007, 35:795-803.
41. Gilmartin M.R., Helmstetter F.J. Trace and contextual fear conditioning require neural activity and NMDA receptor-dependent transmission in the medial prefrontal cortex. Learn. Mem 2010, 17:289-296.
42. Green K.N., Billings L.M., Roozendaal B., McGaugh J.L., LaFerla F.M. Glucocorticoids increase amyloid-beta and tau pathology in a mouse model of Alzheimer's disease. J. Neurosci 2006, 26:9047-9056.
43. Gupta R.R., Sen S., Diepenhorst L.L., Rudick C.N., Maren S. Estrogen modulates sexually dimorphic contextual fear conditioning and hippocampal long-term potentiation (LTP) in rats(1). Brain Res 2001, 888:356-365.
44. Heuser I.J., Gotthardt U., Schweiger U., Schmider J., Lammers C.H., Dettling M., Holsboer F. Age-associated changes of pituitary-adrenocortical hormone regulation in humans: Importance of gender. Neurobiol. Aging 1994, 15:227-231.
45. Hodes G.E., Shors T.J. Distinctive stress effects on learning during puberty. Horm. Behav 2005, 48:163-171.
46. Jacome L.F., Gautreaux C., Inagaki T., Mohan G., Alves S., Lubbers L.S., Luine V. Estradiol and ERbeta agonists enhance recognition memory, and DPN, an ERbeta agonist, alters brain monoamines. Neurobiol. Learn. Mem 2010, 94:488-498.
47. Joffe H., Hall J.E., Gruber S., Sarmiento I.A., Cohen L.S., Yurgelun-Todd D., Martin K.A. Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women. Menopause 2006, 13:411-422.
48. Kajantie E., Phillips D.I. The effects of sex and hormonal status on the physiological response to acute psychosocial stress. Psychoneuroendocrinology 2006, 31:151-178.
49. Kang J.E., Cirrito J.R., Dong H., Csernansky J.G., Holtzman D.M. Acute stress increases interstitial fluid amyloid-beta via corticotropin-releasing factor and neuronal activity. Proc. Natl. Acad. Sci. U. S. A 2007, 104:10673-10678.
50. Keenan P.A., Ezzat W.H., Ginsburg K., Moore G.J. Prefrontal cortex as the site of estrogen's effect on cognition. Psychoneuroendocrinology 2001, 26:577-590.
51. Kessler R.C., McGonagle K.A., Swartz M., Blazer D.G., Nelson C.B. Sex and depression in the National Comorbidity Survey. I: Lifetime prevalence, chronicity and recurrence. J. Affect. Disord 1993, 29:85-96.
52. Klaiber E.L., Broverman D.M., Vogel W., Peterson L.G., Snyder M.B. Individual differences in changes in mood and platelet monoamine oxidase (MAO) activity during hormonal replacement therapy in menopausal women. Psychoneuroendocrinology 1996, 21:575-592.
53. Komesaroff P.A., Esler M.D., Sudhir K. Estrogen supplementation attenuates glucocorticoid and catecholamine responses to mental stress in perimenopausal women. J. Clin. Endocrinol. Metab 1999, 84:606-610.
54. Kronforst-Collins M.A., Disterhoft J.F. Lesions of the caudal area of rabbit medial prefrontal cortex impair trace eyeblink conditioning. Neurobiol. Learn. Mem 1998, 69:147-162.
55. Kudielka B.M., Schmidt-Reinwald A.K., Hellhammer D.H., Kirschbaum C. Psychological and endocrine responses to psychosocial stress and dexamethasone/corticotropin-releasing hormone in healthy postmenopausal women and young controls: the impact of age and a two-week estradiol treatment. Neuroendocrinology 1999, 70:422-430.
56. Laughlin G.A., Barrett-Connor E. Sexual dimorphism in the influence of advanced aging on adrenal hormone levels: The Rancho Bernardo Study. J. Clin. Endocrinol. Metab 2000, 85:3561-3568.
57. Leon-Carrion J., Martin-Rodriguez J.F., Madrazo-Atutxa A., Soto-Moreno A., Venegas-Moreno E., Torres-Vela E., Benito-López P., Gálvez M.A., Tinahones F.J., Leal-Cerro A. Evidence of cognitive and neurophysiological impairment in patients with untreated naive acromegaly. J. Clin. Endocrinol. Metab 2010, 95:4367-4379.
58. Leuner B., Mendolia-Loffredo S., Shors T.J. High levels of estrogen enhance associative memory formation in ovariectomized females. Psychoneuroendocrinology 2004, 29:883-890.
59. Lewis R.S., Nikolova A., Chang D.J., Weekes N.Y. Examination stress and components of working memory. Stress 2008, 11:108-114.
60. Li R., Shen Y., Yang L.B., Lue L.F., Finch C., Rogers J. Estrogen enhances uptake of amyloid beta-protein by microglia derived from the human cortex. J. Neurochem 2000, 75:1447-1454.
61. Liston C., McEwen B.S., Casey B.J. Psychosocial stress reversibly disrupts prefrontal processing and attentional control. Proc. Natl. Acad. Sci. U. S. A 2009, 106:912-917.
62. Loucks T.L., Berga S.L. Does postmenopausal estrogen use confer neuroprotection?. Semin. Reprod. Med 2009, 27:260-274.
63. Luine V.N., Richards S.T., Wu V.Y., Beck K.D. Estradiol enhances learning and memory in a spatial memory task and effects levels of monoaminergic neurotransmitters. Horm. Behav 1998, 34:149-162.
64. Lupien S.J., Fiocco A., Wan N., Maheu F., Lord C., Schramek T., Tu M.T. Stress hormones and human memory function across the lifespan. Psychoneuroendocrinology 2005, 30:225-242.
65. Lupien S.J., Wilkinson C.W., Brière S., Ng Ying Kin N.M., Meaney M.J., Nair N.P. Acute modulation of aged human memory by pharmacological manipulation of glucocorticoids. J. Clin. Endocrinol. Metab 2002, 87:3798-3807.
66. Maki P.M., Resnick S.M. Longitudinal effects of estrogen replacement therapy on PET cerebral blood flow and cognition. Neurobiol. Aging 2000, 21:373-383.
67. Maki P.M., Sundermann E. Hormone therapy and cognitive function. Hum. Reprod. Update 2009, 15:667-681.
68. Maki P.M., Zonderman A.B., Resnick S.M. Enhanced verbal memory in nondemented elderly women receiving hormone-replacement therapy. Am. J. Psychiatry 2001, 158:227-233.
69. Marin R., Guerra B., Morales A., Diaz M., Alonso R. An ICI 182,780-sensitive, membrane-related estrogen receptor contributes to estrogenic neuroprotective actions against amyloid-beta toxicity. Ann. N. Y. Acad. Sci 2003, 1007:108-116.
70. Mayeux R., Honig L.S., Tang M.X., Manly J., Stern Y., Schupf N., Mehta P.D. Plasma A[beta]40 and A[beta]42 and Alzheimer's disease: relation to age, mortality, and risk. Neurology 2003, 61:1185-1190.
71. McEwen B.S. Protective and damaging effects of stress mediators. N Engl J. Med 1998, 338:171-179.
72. McEwen B.S. Invited review: Estrogens effects on the brain: multiple sites and molecular mechanisms. J. Appl. Physiol 2001, 91:2785-2801.
73. McEwen B.S. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol. Rev 2007, 87:873-904.
74. McEwen B.S. Central effects of stress hormones in health and disease: Understanding the protective and damaging effects of stress and stress mediators. Eur. J. Pharmacol 2008, 583:174-185.
75. Mehta P.D., Pirttilä T., Mehta S.P., Sersen E.A., Aisen P.S., Wisniewski H.M. Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease. Arch. Neurol 2000, 57:100-105.
76. Meinzer M., Flaisch T., Wilser L., Eulitz C., Rockstroh B., Conway T., Gonzalez-Rothi L., Crosson B. Neural signatures of semantic and phonemic fluency in young and old adults. J. Cogn. Neurosci 2009, 21:2007-2018.
77. Miller K.J., Conney J.C., Rasgon N.L., Fairbanks L.A., Small G.W. Mood symptoms and cognitive performance in women estrogen users and nonusers and men. J. Am. Geriatr. Soc 2002, 50:1826-1830.
78. Newhouse P.A., Dumas J., Wilkins H., Coderre E., Sites C.K., Naylor M., Benkelfat C., Young S.N. Estrogen treatment impairs cognitive performance after psychosocial stress and monoamine depletion in postmenopausal women. Menopause 2010, 17:860-873.
79. Okereke O.I., Xia W., Selkoe D.J., Grodstein F. Ten-year change in plasma amyloid beta levels and late-life cognitive decline. Arch. Neurol 2009, 66:1247-1253.
80. Otte C., Hart S., Neylan T.C., Marmar C.R., Yaffe K., Mohr D.C. A meta-analysis of cortisol response to challenge in human aging: importance of gender. Psychoneuroendocrinology 2005, 30:80-91.
81. Petanceska S.S., Nagy V., Frail D., Gandy S. Ovariectomy and 17beta-estradiol modulate the levels of Alzheimer's amyloid beta peptides in brain. Neurology 2000, 54:2212-2217.
82. Petrides M., Milner B. Deficits on subject-ordered tasks after frontal- and temporal-lobe lesions in man. Neuropsychologia 1982, 20:249-262.
83. Pham K., Nacher J., Hof P.R., McEwen B.S. Repeated restraint stress suppresses neurogenesis and induces biphasic PSA-NCAM expression in the adult rat dentate gyrus. Eur. J. Neurosci 2003, 17:879-886.
84. Pluchino N., Genazzani A.D., Bernardi F., Casarosa E., Pieri M., Palumbo M., Picciarelli G., Gabbanini M., Luisi M., Genazzani A.R. Tibolone, transdermal estradiol or oral estrogen-progestin therapies: effects on circulating allopregnanolone, cortisol and dehydroepiandrosterone levels. Gynecol. Endocrinol 2005, 20:144-149.
85. Polo-Kantola P., Portin R., Polo O., Helenius H., Irjala K., Erkkola R. The effect of short-term estrogen replacement therapy on cognition: a randomized, double-blind, cross-over trial in postmenopausal women. Obstet. Gynecol 1998, 91:459-466.
86. Puder J.J., Freda P.U., Goland R.S., Wardlaw S.L. Estrogen modulates the hypothalamic-pituitary-adrenal and inflammatory cytokine responses to endotoxin in women. J. Clin. Endocrinol. Metab 2001, 86:2403-2408.
87. Reger M.A., Watson G.S., Green P.S., Wilkinson C.W., Baker L.D., Cholerton B., Fishel M.A., Plymate S.R., Breitner J.C., DeGroodt W., Mehta P., Craft S. Intranasal insulin improves cognition and modulates beta-amyloid in early. Adv. Neurol 2008, 70:440-448.
88. Sapolsky R.M. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch. Gen. Psychiatry 2000, 57:925-935.
89. Schoorlemmer R.M., Peeters G.M., van Schoor N.M., Lips P. Relationships between cortisol level, mortality and chronic diseases in older persons. Clin. Endocrinol. (Oxf.) 2009, 71:779-786.
90. Schwabe L., Wolf O.T. Learning under stress impairs memory formation. Neurobiol. Learn. Mem 2010, 93:183-188.
91. Seeman T.E., McEwen B.S., Singer B.H., Albert M.S., Rowe J.W. Increase in urinary cortisol excretion and memory declines: MacArthur studies of successful aging. J. Clin. Endocrinol. Metab 1997, 82:2458-2465.
92. Sherwin B.B. Estrogen and cognitive aging in women. Neuroscience 2006, 138:1021-1026.
93. Sherwin B.B. Estrogen therapy: is time of initiation critical for neuroprotection?. Nat. Rev. Endocrinol 2009, 5:620-627.
94. Shors T.J., Chua C., Falduto J. Sex differences and opposite effects of stress on dendritic spine density in the male versus female hippocampus. J. Neurosci 2001, 21:6292-6297.
95. Shors T.J., Falduto J., Leuner B. The opposite effects of stress on dendritic spines in male vs. female rats are NMDA receptor-dependent. Eur. J. Neurosci 2004, 19:145-150.
96. Shors T.J., Lewczyk C., Pacynski M., Mathew P.R., Pickett J. Stages of estrous mediate the stress-induced impairment of associative learning in the female rat. Neuroreport 1998, 9:419-423.
97. Shors T.J., Pickett J., Wood G., Paczynski M. Acute stress persistently enhances estrogen levels in the female rat. Stress 1999, 3:163-171.
98. Smith Y.R., Love T., Persad C.C., Tkaczyk A., Nichols T.E., Zubieta J.K. Impact of combined estradiol and norethindrone therapy on visuospatial working memory assessed by functional magnetic resonance imaging. J. Clin. Endocrinol. Metab 2006, 91:4476-4481.
99. Spieler D.H., Balota D.A., Faust M.E. Stroop performance in healthy younger and older adults and in individuals with dementia of the Alzheimer's type. J. Exp. Psychol. Hum. Percept. Perform 1996, 22:461-479.
100. Viau V., Meaney M.J. Alpha1 adrenoreceptors mediate the stimulatory effects of oestrogen on stress-related hypothalamic-pituitary-adrenal activity in the female rat. J. Neuroendocrinol 2004, 16:72-78.
101. Voytko M.L., Tinkler G.P., Browne C., Tobin J.R. Neuroprotective effects of estrogen therapy for cognitive and neurobiological profiles of monkey models of menopause. Am. J. Primatol 2009, 71:794-801.
102. Weber-Hamann B., Blum W.F., Kratzsch J., Gilles M., Heuser I., Deuschle M. Insulin-like growth factor-I (IGF-I) serum concentrations in depressed patients: relationship to saliva cortisol and changes during antidepressant treatment. Pharmacopsychiatry 2009, 42:23-28.
103. Weerda R., Muehlhan M., Wolf O.T., Thiel C.M. Effects of acute psychosocial stress on working memory related brain activity in men. Hum. Brain Mapp 2010, 31:1418-1429.
104. Wegesin D.J., Stern Y. Effects of hormone replacement therapy and aging on cognition: evidence for executive dysfunction. Neuropsychol. Dev. Cogn. B Aging Neuropsychol. Cogn 2007, 14:301-328.
105. Weiser M.J., Handa R.J. Estrogen impairs glucocorticoid dependent negative feedback on the hypothalamic-pituitary-adrenal axis via estrogen receptor alpha within the hypothalamus. Neuroscience 2009, 159:883-895.
106. Wolkowitz O.M., Reus V.I., Weingartner H., Thompson K., Breier A., Doran A., Rubinow D., Pickar D. Cognitive effects of corticosteroids. Am. J. Psychiatry 1990, 147:1297-1303.
107. Wood G., Shors T. Stress facilitates classical conditioning in males, but impairs classical conditioning in females through activational effects of ovarian hormones. Proc. Natl. Acad. Sci. U. S. A 1998, 95:1066-1071.
108. Wood G.E., Beylin A.V., Shors T.J. The contribution of adrenal and reproductive hormones to the opposing effects of stress on trace conditioning in males versus females. Behav. Neurosci 2001, 115:175-187.
109. Yeni-Komshian H., Carantoni M., Abbasi F., Reaven G.M. Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. Diabetes Care 2000, 23:171-175.
110. Young E.A., Ribeiro S.C. Sex differences in the ACTH response to 24H metyrapone in depression. Brain Res 2006, 1126:148-155.
111. Yuen E.Y., Liu W., Karatsoreos I.N., Ren Y., Feng J., McEwen B.S., Yan Z. Mechanisms for acute stress-induced enhancement of glutamatergic transmission and working memory. Mol Psychiatry 2011, 16:156-170.